Arkolith/Insider Trading/ATOS/Form 4

Finn Jonathan

DirectorATOSSA THERAPEUTICS, INC. (ATOS) · full profile →Form 4 · filed Apr 11, 2024
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 10, 2024Buy(P)25K$1.77$44K25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-043690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML